BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20800692)

  • 1. Persistent cognitive and motor deficits after successful antimalarial treatment in murine cerebral malaria.
    Dai M; Reznik SE; Spray DC; Weiss LM; Tanowitz HB; Gulinello M; Desruisseaux MS
    Microbes Infect; 2010 Dec; 12(14-15):1198-207. PubMed ID: 20800692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.
    Reis PA; Comim CM; Hermani F; Silva B; Barichello T; Portella AC; Gomes FC; Sab IM; Frutuoso VS; Oliveira MF; Bozza PT; Bozza FA; Dal-Pizzol F; Zimmerman GA; Quevedo J; Castro-Faria-Neto HC
    PLoS Pathog; 2010 Jun; 6(6):e1000963. PubMed ID: 20585569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA.
    Desruisseaux MS; Gulinello M; Smith DN; Lee SC; Tsuji M; Weiss LM; Spray DC; Tanowitz HB
    J Infect Dis; 2008 Jun; 197(11):1621-7. PubMed ID: 18419550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of uncomplicated Plasmodium berghei ANKA malaria on memory and anxiety-like behaviour in C57BL/6 mice.
    de Sousa LP; de Almeida RF; Ribeiro-Gomes FL; de Moura Carvalho LJ; E Souza TM; de Souza DOG; Daniel-Ribeiro CT
    Parasit Vectors; 2018 Mar; 11(1):191. PubMed ID: 29554958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment.
    Dai M; Freeman B; Shikani HJ; Bruno FP; Collado JE; Macias R; Reznik SE; Davies P; Spray DC; Tanowitz HB; Weiss LM; Desruisseaux MS
    PLoS One; 2012; 7(10):e44117. PubMed ID: 23082110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.
    Reis PA; Estato V; da Silva TI; d'Avila JC; Siqueira LD; Assis EF; Bozza PT; Bozza FA; Tibiriça EV; Zimmerman GA; Castro-Faria-Neto HC
    PLoS Pathog; 2012 Dec; 8(12):e1003099. PubMed ID: 23300448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of α-Tocopheryloxy Acetic Acid on the Infection of Mice with Plasmodium berghei ANKA In Vivo and Humans with P. falciparum In Vitro.
    Ariefta NR; Kume A; Nishikawa Y; Taniguchi T; Umemiya-Shirafuji R; Kasai S; Suzuki H
    Acta Parasitol; 2022 Dec; 67(4):1514-1520. PubMed ID: 35951222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin Prevents Brain Damage and Neurocognitive Impairment Induced by
    Ataide BJA; Kauffmann N; Mendes NSF; Torres MLM; Dos Anjos LM; Passos ADCF; de Moraes SAS; Batista EJO; Herculano AM; Oliveira KRHM
    Front Cell Infect Microbiol; 2020; 10():541624. PubMed ID: 33102250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria.
    de Miranda AS; Brant F; Vieira LB; Rocha NP; Vieira ÉLM; Rezende GHS; de Oliveira Pimentel PM; Moraes MFD; Ribeiro FM; Ransohoff RM; Teixeira MM; Machado FS; Rachid MA; Teixeira AL
    Mol Neurobiol; 2017 Nov; 54(9):7063-7082. PubMed ID: 27796746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Malaria Causes Enduring Behavioral and Molecular Changes in Mice Brain Without Causing Gross Histopathological Damage.
    Souza TL; Grauncke ACB; Ribeiro LR; Mello FK; Oliveira SM; Brant F; Machado FS; Oliveira MS
    Neuroscience; 2018 Jan; 369():66-75. PubMed ID: 29113928
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Elphinstone RE; Besla R; Shikatani EA; Lu Z; Hausladen A; Davies M; Robbins CS; Husain M; Stamler JS; Kain KC
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28674030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-infection with Trypanosoma cruzi protects mice against early death by neurological or pulmonary disorders induced by Plasmodium berghei ANKA.
    Egima CM; Macedo SF; Sasso GR; Covarrubias C; Cortez M; Maeda FY; Costa FT; Yoshida N
    Malar J; 2007 Jul; 6():90. PubMed ID: 17620126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral artesunate prevents Plasmodium berghei Anka infection in mice.
    Gumede B; Folb P; Ryffel B
    Parasitol Int; 2003 Mar; 52(1):53-9. PubMed ID: 12543147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria.
    Campos AC; Brant F; Miranda AS; Machado FS; Teixeira AL
    Neuroscience; 2015 Mar; 289():166-80. PubMed ID: 25595981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and genes regulation of cerebral malaria upon Zizyphus spina-christi treatment in a murine model.
    Mubaraki MA; Hafiz TA; Al-Quraishy S; Dkhil MA
    Microb Pathog; 2017 Jun; 107():69-74. PubMed ID: 28336326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
    Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
    J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic angiotensin II peptide derivatives confer protection against cerebral and severe non-cerebral malaria in murine models.
    Silva AF; Torres MDT; Silva LS; Alves FL; Miranda A; Oliveira VX; de la Fuente-Nunez C; Pinheiro AAS
    Sci Rep; 2024 Feb; 14(1):4682. PubMed ID: 38409185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
    Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
    Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Toll-like receptors by chloroquine protects mice from experimental cerebral malaria.
    Zhu X; Pan Y; Li Y; Jiang Y; Shang H; Gowda DC; Cui L; Cao Y
    Int Immunopharmacol; 2012 Aug; 13(4):392-7. PubMed ID: 22659438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosoma co-infection protects against brain pathology but does not prevent severe disease and death in a murine model of cerebral malaria.
    Bucher K; Dietz K; Lackner P; Pasche B; Fendel R; Mordmüller B; Ben-Smith A; Hoffmann WH
    Int J Parasitol; 2011 Jan; 41(1):21-31. PubMed ID: 20708623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.